| Drug Name |
Abrocitinib |
| Drug ID |
BADD_D02527 |
| Description |
Abrocitinib is under investigation in clinical trial NCT03796676 (JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis). |
| Indications and Usage |
Not Available |
| Marketing Status |
investigational |
| ATC Code |
D11AH08 |
| DrugBank ID |
DB14973
|
| KEGG ID |
D11400
|
| MeSH ID |
C000634427
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
53869-1335; 0069-0235; 63539-236; 63539-336; 63539-436; 53869-1435; 0069-0335; 0069-0435; 53869-1235 |
| UNII |
73SM5SF3OR
|
| Synonyms |
abrocitinib | N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide | N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-propane-1-sulfonamide | 1-Propanesulfonamide, N-(cis-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclobutyl)- | PF-04965842 |
